Quest Diagnostics to Host Investor Day on March 16, 2023
Quest Diagnostics (NYSE: DGX) will hold an Investor Day on March 16, 2023, at the New York Stock Exchange, aimed at institutional investors and financial analysts. Key executives, including CEO Jim Davis and CFO Sam Samad, will discuss insights into the U.S. laboratory market, the company’s business strategy, capital priorities, and long-term outlook. Advance registration is required, and a live webcast will be available through Quest's Investor Relations website. An archived version of the event will also be accessible post-event, further emphasizing Quest’s commitment to transparency and investor engagement.
- None.
- None.
During the event, Jim Davis, CEO and President, Sam Samad, Executive Vice President & CFO, and other senior executives will provide updated views of the
Advance registration is required. To register for the event, please go to: Quest Diagnostics Investor Day 2023 Registration.
A live webcast of the event will be broadcast on the Quest Diagnostics Investor Relations website.
An archived copy of the webcast will be available on the Quest Diagnostics Investor Relations website following the conclusion of the event.
About Quest Diagnostics
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-host-investor-day-on-march-16-2023-301745132.html
SOURCE
FAQ
When is Quest Diagnostics' Investor Day scheduled?
Where will the Quest Diagnostics Investor Day take place?
Who will present at the Quest Diagnostics Investor Day?
How can I register for the Quest Diagnostics Investor Day?
Will there be a webcast of the Quest Diagnostics Investor Day?